Microglia undergo dynamic structural and transcriptional changes during the immune response to traumatic brain injury (TBI). For example, TBI causes microglia to form rod-shaped trains in the cerebral cortex, but their contribution to inflammation and pathophysiology is unclear. The purpose of this study was to determine the origin and alignment of rod microglia and to determine the role of microglia in propagating persistent cortical inflammation. Here, diffuse TBI in mice was modeled by midline fluid percussion injury (FPI). Bone marrow chimerism and BrdU pulse-chase experiments revealed that rod microglia derived from resident microglia with limited proliferation. Novel data also show that TBI-induced rod microglia were proximal to axotomized neurons, spatially overlapped with dense astrogliosis, and aligned with apical pyramidal dendrites. Furthermore, rod microglia formed adjacent to hypertrophied microglia, which clustered among layer V pyramidal neurons. To better understand the contribution of microglia to cortical inflammation and injury, microglia were eliminated prior to TBI by CSF1R antagonism (PLX5622). Microglial elimination did not affect cortical neuron axotomy induced by TBI, but attenuated rod microglial formation and astrogliosis. Analysis of 262 immune genes revealed that TBI caused profound cortical inflammation acutely (8 hr) that progressed in nature and complexity by 7 dpi. For instance, gene expression related to complement, phagocytosis, toll-like receptor signaling, and interferon response were increased 7 dpi. Critically, these acute and chronic inflammatory responses were prevented by microglial elimination. Taken together, TBI-induced neuronal injury causes microglia to structurally associate with neurons, augment astrogliosis, and propagate diverse and persistent inflammatory/immune signaling pathways.
Pubmed ID: 30378170 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets NeuN
View all literature mentionsThis polyclonal targets Iba1
View all literature mentionsThis monoclonal targets Mouse CD45
View all literature mentionsThis monoclonal targets Ly6c antibody [ER-MP20]
View all literature mentionsThis polyclonal targets P2ry12
View all literature mentionsThis monoclonal targets Chemical BrdU
View all literature mentionsThis polyclonal targets Mouse GFAP
View all literature mentionsMus musculus with name C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ from IMSR.
View all literature mentionsThis monoclonal targets Ly6c antibody [ER-MP20]
View all literature mentionsThis polyclonal targets Iba1
View all literature mentionsThis monoclonal targets NeuN
View all literature mentionsThis polyclonal targets P2ry12
View all literature mentionsMus musculus with name C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ from IMSR.
View all literature mentionsThis polyclonal targets Mouse GFAP
View all literature mentionsThis monoclonal targets Mouse CD45
View all literature mentionsThis monoclonal targets Chemical BrdU
View all literature mentions